Additionally, both RRA analysis of 9 Affymetrix datasets and RRA analysis of 7 Illumina datasets consistently identified CD160 as the most aberrantly expressed co-signaling molecule in autoimmune diseases (Supplementary Tables 7, 8, Supplementary Figures 6, 7), which suggested that the aberrant expression of CD160 in autoimmune diseases was also not significantly influenced by types of platforms (Illumina or Affymetrix). Here, CD160 is linked to autoimmune disease.